Haldol and Afinitor drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Haldol (haloperidol) and Afinitor (everolimus). Common drug interactions include erythema among females and atelectasis among males.

The phase IV clinical study analyzes what interactions people have when they take Haldol and Afinitor. It is created by eHealthMe based on reports of 24 people who take the same drugs from the FDA, and is updated regularly.

What is Haldol?

Haldol has active ingredients of haloperidol. It is often used in schizophrenia. eHealthMe is studying from 23,102 Haldol users. Check the latest studies of Haldol.

What is Afinitor?

Afinitor has active ingredients of everolimus. It is often used in breast cancer metastatic. eHealthMe is studying from 41,680 Afinitor users. Check the latest studies of Afinitor.



On Jul, 14, 2026

24 people who take Haldol and Afinitor together, and have interactions are studied.

Haldol and Afinitor drug interactions.

What are the common drug interactions of Haldol and Afinitor, by gender? *:

female:

  1. Erythema (redness of the skin)
  2. Oropharyngeal pain
  3. Blood prolactin increased
  4. Hallucination, auditory (perceiving sounds without auditory stimulus)
  5. Malaise (a feeling of general discomfort or uneasiness)
  6. Renal failure (kidney dysfunction)
  7. Skin disorder (skin disease)
  8. Weight increased
  9. Abdominal pain
  10. Acne (skin problems that cause pimples)

male:

  1. Atelectasis (partial or complete collapse of the lung)
  2. Death
  3. Blood potassium increased
  4. Disease progression
  5. Diverticulitis (digestive disease which involves the formation of pouches (diverticula) within the bowel wall)
  6. Pneumonia
  7. Sepsis (a severe blood infection that can lead to organ failure and death)
  8. Blood creatinine increased
  9. Fracture
  10. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)

What are the common drug interactions of Haldol and Afinitor, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Blood potassium increased

20-29:

  1. Oropharyngeal pain
  2. Blood prolactin increased
  3. Hallucination, auditory (perceiving sounds without auditory stimulus)
  4. Malaise (a feeling of general discomfort or uneasiness)
  5. Renal failure (kidney dysfunction)
  6. Skin disorder (skin disease)
  7. Weight increased
  8. Abdominal pain
  9. Acne (skin problems that cause pimples)
  10. Blood pressure increased

30-39:

n/a

40-49:

n/a

50-59:

  1. Anaemia (lack of blood)
  2. Haemolysis (breaking open of red blood cells and the release of haemoglobin into the surrounding fluid)
  3. Thrombocytopenia (decrease of platelets in blood)

60+:

  1. Pneumonia
  2. Atelectasis (partial or complete collapse of the lung)
  3. Flushing (the warm, red condition of human skin)
  4. Gamma-glutamyltransferase increased
  5. Haematocrit decreased
  6. Haemoglobin decreased
  7. Hilar lymphadenopathy (disease of the lymph nodes due to infection)
  8. Lymphadenopathy mediastinal (an enlargement of the lymph nodes in the part of the chest that separates the lungs)
  9. Lymphoedema (localized fluid retention and tissue swelling)
  10. Metastases to lung (cancer spreads to lung)

What are the existing conditions these people have? *

  1. Angiomyolipoma (most common benign tumour of the kidney): 7 people, 29.17%
  2. Pain: 5 people, 20.83%
  3. Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 5 people, 20.83%
  4. Nausea (feeling of having an urge to vomit): 4 people, 16.67%
  5. Mental Disorder (a psychological term for a mental or behavioural pattern or anomaly that causes distress or disability): 3 people, 12.50%
  6. Constipation: 3 people, 12.50%
  7. Tumor: 2 people, 8.33%
  8. High Blood Pressure: 2 people, 8.33%
  9. Haemorrhoids (a swollen vein or group of veins in the region of the anus): 2 people, 8.33%
  10. Delirium (wild excitement): 2 people, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Haldol and Afinitor?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Haldol and Afinitor:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Haldol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Afinitor:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Haldol and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Afinitor and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on haloperidol and everolimus (the active ingredients of Haldol and Afinitor, respectively), and Haldol and Afinitor (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: